Do Hedge Funds Love Eagle Pharmaceuticals Inc (EGRX)?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th.
Eagle Pharmaceuticals Inc. (EGRX)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Hedge Funds Have Never Been More Bullish On Eagle Pharmaceuticals Inc (EGRX)
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
Hedge Funds Are Selling Eagle Pharmaceuticals Inc (EGRX)
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns.
13G Filing: Iridian Asset Management and Eagle Pharmaceuticals Inc. (EGRX)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing...
13G Filing: Iridian Asset Management and Eagle Pharmaceuticals Inc. (EGRX)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing...
13G Filing: Park West Asset Management and Eagle Pharmaceuticals Inc. (EGRX)
You can access the original SEC filing by clicking here.
Is Eagle Pharmaceuticals Inc (EGRX) A Good Stock To Buy?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Eagle Pharmaceuticals Inc. (EGRX): Douglas Braunstein of Hudson Executive Capital Appointed Chairman
A newly-amended 13D filing with the US Securities and Exchange Commission revealed that Douglas Braunstein of Hudson Executive Capital has been appointed as chairman of the board of directors and chairman...
Billionaire Halvorsen Makes 2 Big Bets on Natural Gas, While Take-Two Interactive and Eagle Pharmaceuticals Get Some Love
It is widely-known that hedge fund strategies vary quite a lot and thus so do their targets and bets.
13G Filing: Park West Asset Management and Eagle Pharmaceuticals, Inc. (EGRX)
Peter Park's Park West Asset Management has recently reported its position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) through a 13G filing with the Securities and Exchange Commission.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
